![Michael Weiss](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Weiss
Amministratore Delegato presso
TG THERAPEUTICS, INC.
Patrimonio netto: 377 M $ in data 31/05/2026
Profilo
Michael S. Weiss è presidente di Checkpoint Therapeutics, Inc., presidente esecutivo di Mustang Bio, Inc., partner di Opus Point Partners Management LLC, partner e portfolio manager di Opus Point Partners LLC e presidente esecutivo, presidente e amministratore delegato di TG Therapeutics, Inc. Fa parte del Consiglio di amministrazione di Cyprium Therapeutics, Inc., Fortress Biotech, Inc., Caelum Biosciences, Inc., Cellvation, Inc. e Helocyte, Inc. Weiss è stato precedentemente impiegato come presidente di National Holdings Corp., direttore non esecutivo di Avenue Therapeutics, Inc., copresidente di CB Pharma Acquisition Corp., presidente esecutivo di IASO Pharma, Inc, un presidente di XTL Biopharmaceuticals Ltd., un presidente e amministratore delegato di Keryx Biopharmaceuticals, Inc., un presidente e amministratore delegato di ACCESS Oncology, Inc., un presidente di Paligent, Inc., un fiduciario di Cancer Care, Inc. e un avvocato di Cravath, Swaine & Moore LLP. È stato anche membro del consiglio di amministrazione di Healthcare Integrated Services, Inc. e Genta, Inc. Si è laureato alla State University of New York ad Albany e si è laureato alla Columbia Law School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 14/04/2026 | 9.778.086 ( 6,39% ) | 371 M $ | 31/05/2026 | |
| 16/04/2026 | 2.276.562 ( 6,85% ) | 6 M $ | 31/05/2026 | |
| 18/11/2025 | 325 ( 0% ) | 218 $ | 31/05/2026 |
Posizioni attive di Michael Weiss
| Società | Posizione | Inizio |
|---|---|---|
| TG THERAPEUTICS, INC. | Amministratore Delegato | 29/12/2011 |
| FORTRESS BIOTECH, INC. | Direttore/Membro del Consiglio | 20/12/2013 |
| MUSTANG BIO, INC. | Presidente | 01/05/2015 |
Cyprium Therapeutics, Inc.
 Cyprium Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for the treatment of Menkes disease and related copper metabolism disorders | Fondatore | 01/01/2017 |
Cellvation, Inc.
 Cellvation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cellular therapeutics for treatment of traumatic brain injury | Direttore/Membro del Consiglio | - |
Helocyte, Inc.
 Helocyte, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops novel immunotherapies for the prevention and treatment of cancer and infectious disease | Direttore/Membro del Consiglio | - |
Baergic Bio, Inc.
 Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs for treatment of central nervous system disorders | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Michael Weiss
| Società | Posizione | Fine |
|---|---|---|
| CHECKPOINT THERAPEUTICS, INC. | Amministratore Delegato | 01/12/2016 |
| AVENUE THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 08/02/2019 |
| ░░░░ ░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Michael Weiss
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
39
Relazioni di 1° grado
25
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 25 |
|---|---|
Paligent, Inc.
 Paligent, Inc. Financial ConglomeratesFinance Development stage company | Finance |
TG Therapeutics, Inc.
 TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
National Holdings Corp.
 National Holdings Corp. Investment Banks/BrokersFinance Operates as a holding company whose subsidiaries provides securities brokerage services | Finance |
Healthcare Integrated Services, Inc.
 Healthcare Integrated Services, Inc. Medical/Nursing ServicesHealth Services Operates fixed-site magnetic resonance imaging centers | Health Services |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical drugs | Health Technology |
Genta, Inc.
 Genta, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical research and development | Health Technology |
IASO Pharma, Inc.
 IASO Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic products | Health Technology |
Fortress Biotech, Inc.
 Fortress Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and biotechnology products | Health Technology |
XTL Biopharmaceuticals Ltd.
 XTL Biopharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops pharmaceutical drugs for the treatment of autoimmune diseases | Health Technology |
Cravath, Swaine & Moore LLP
 Cravath, Swaine & Moore LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
State University of New York at Albany
 State University of New York at Albany Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cancer Care, Inc.
 Cancer Care, Inc. Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
Opus Point Partners Management LLC
 Opus Point Partners Management LLC Investment ManagersFinance OPPM invests in and assists biotechnology and healthcare companies in developing and commercializing novel medicines and diagnostic tools. | Finance |
Columbia Law School
 Columbia Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Origo Acquisition Corp.
 Origo Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Checkpoint Therapeutics, Inc.
 Checkpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Opus Point Partners LLC
 Opus Point Partners LLC Financial ConglomeratesFinance Provides investment services | Finance |
Avenue Therapeutics, Inc.
 Avenue Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops and commercializes therapies for neurological diseases | Health Technology |
Helocyte, Inc.
Helocyte, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops novel immunotherapies for the prevention and treatment of cancer and infectious disease | Health Technology |
Mustang Bio, Inc.
 Mustang Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops novel immunotherapy''s | Health Technology |
Cyprium Therapeutics, Inc.
Cyprium Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for the treatment of Menkes disease and related copper metabolism disorders | Health Technology |
Cellvation, Inc.
Cellvation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cellular therapeutics for treatment of traumatic brain injury | Health Technology |
Caelum Biosciences, Inc.
 Caelum Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that develops treatments for AL amyloidosis, rare and life-threatening hematologic disorders | Health Technology |
Baergic Bio, Inc.
Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs for treatment of central nervous system disorders | Health Technology |
